Douglas Janzen

Biography

 Mr. Janzen has deep experience in the cardiovascular industry having served as the past President and CEO and Director of Cardiome Pharma Corp. (TSX: COM; NASDAQ: CRME), a company that develops drugs to treat or prevent cardiovascular diseases. Mr. Janzen previously served as the company’s President and Chief Business Officer, since March 2006, and prior to that as CFO. Mr. Janzen has served as a director on a number of public and private boards of therapeutic and device companies including Sentinelle Medical, ICo Therapeutics and Bradmer Pharmaceuticals. Mr Janzen also serves as the Chairman of Life Sciences British Columbia and as a Director of Biotech Canada. Mr. Janzen also has extensive experience in corporate banking and financing within the biotechnology sector as an analyst and the Head of Research at Loewen Ondaatje McCutheon from 1997 to 2001 and then as Managing Director, Health Sciences andPartner at Sprott Securities Inc. (now Cormark) from 2001 to 2003.

Research Interest

  Pharmaceutical Sciences